Health Status
Conditions
Brief summary
Observational study about quality of life in postmenopausal women taking coenzyme Q compared to another group of women of the same age who do not take it
Detailed description
Observational study to evaluate the subjective assessment performed by healthy postmenopausal women who are taking coenzyme Q for 3 months, compared with other groups of the same characteristics that do not take it
Interventions
DIETARY_SUPPLEMENTCoenzima Q - QubiquinolCoenzyme Q - Qubiquinol
Patients in the active group will take one tablet a day orally
Sponsors
Dr. Santiago Palacios
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Inclusion criteria
* Postmenopausal woman between 45 and 65 years old * Woman who is taking coenzyme Q-Ubiquinol and who will continue taking at least the next 3 months * Woman not taking Coenzyme Q-Ubiquinol and not going to take it in the next 3 months Exclusión Criteria: * Patients with severe mental illness. * Suspicion or abuse of alcohol or other drugs during the 12 months prior to the selection * Any other consideration or finding that, in the opinion of the investigator, considers the non-participation of the subject in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline Quality of Life at 3 months | Baseline and 3 months | To evaluate the quality of life in healthy postmenopausal women who are taking Coenzyme Q-Ubiquinol for 3 months in comparison with another group that does not take them. The Cervantes Health-Related Quality of Life scale for menopause will be used for this outcome. In that scale next to the 0 and the 5 there are words that describe two opposite answers to the question. Between the 0 and the 5 there are also four boxes numbered 1 to 4. The participants should answer the questions by checking the box that best represents what they think and feel. In other words, they should check 5 if they are completely agree and 0 they are completely disagree. If they are not completely agree or disagree, they should check the boxes in between |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline General Health at 3 months | Baseline and 3 months | Health Scale Euroqol EQ-5D will be used for this outcome |
| Change from Baseline Mood at three months | Baseline and 3 months | An analogic scale will be used for this outcome in wich 0 points is the best mood and 10 points is worst mood |
| Change from Baseline Cramps at three months | Baseline and 3 months | To assess changes in cramps in patients who had them, a general questionnaire about Cramps will be used to assess mainly the intensity and frequency of crambs. Regarding the intensity 0 is the lower pain and 10 is the worst pain |
Countries
Spain
Outcome results
None listed